Regeneration Technologies, Inc.
This article was originally published in The Gray Sheet
Executive SummaryAlachua, Florida human allograft tissue implant processor amends lawsuit against Musculoskeletal Transplant Foundation (MTF) to add charges that MTF made false and misleading claims that its human allograft tissue is sterile. RTI originally filed suit against the non-profit tissue provider in the U.S. District Court for the Northern District of Florida in Gainesville alleging that an MTF advertising campaign disparaged RTI products as unsafe. The suit charges MTF with false advertising, unfair competition and intentional interference with RTI's business relationships (1"The Gray Sheet" June 18, 2001, In Brief)
You may also be interested in...
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.